Chromatin PTEN: Its Regulation And Functions
Chromatin PTEN: Its Regulation And Functions
批准号:
10200691
负责人:
WEI DAI
金额:
$38.35万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2024-07-31
关键词:
AffectAllelesAneuploidyAntineoplastic AgentsBiochemicalC-terminalCancer EtiologyCell CycleCell Cycle ArrestCell ProliferationCell divisionCell physiologyChromatinChromosomal InstabilityChromosomal StabilityCleaved cellDNA DamageDNA RepairDevelopmentDrug DesignExcisionGenesGenome StabilityGenomic InstabilityGenotoxic StressGlioblastomaHumanIn VitroIndividualInheritedLeadLipidsMG132MaintenanceMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of prostateMediatingMitosisMitoticMolecularMolecular AnalysisMolecular TargetMonoubiquitinationMusMutateMutationNormal CellNuclearNuclear ImportNuclear TranslocationPDPK1 genePTEN genePhosphatidylinositol 4,5-DiphosphatePhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPlayPolyubiquitinationPost-Translational Protein ProcessingPredispositionProcessProtein KinaseRNA InterferenceRegulationReportingResearchRoleSecond Messenger SystemsSerineSignal PathwaySignal TransductionTailTestingThreonineTumor Suppressor ProteinsWorkangiogenesiscell growthdrug developmentin vitro Modelin vivointerestmalignant breast neoplasmmouse modelmulticatalytic endopeptidase complexphosphatidylinositol 3,4,5-triphosphatephosphatidylinositol 3,4-diphosphatesegregationtumortumorigenesisubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Chromatin PTEN: Its Regulation And Function
Phosphatase and tensin homolog (PTEN) functions as a major negative regulator of the PI3K signaling
pathway. PTEN is frequently mutated in a variety of human malignancies including glioblastoma, prostate
cancer, and breast cancer. Inherited PTEN mutations cause cancer-susceptibility conditions. PTEN is also
known to have nuclear/chromatin functions, deregulation of which apparently causes chromosomal instability.
However, the exact functions of chromatin PTEN and its molecular regulation remain poorly understood. Past
research shows that proper subcellular localization of PTEN after genotoxic stress is regulated by molecular
mechanisms that involve post-translational modifications. We recently demonstrated that chromatin PTEN
significantly increases during mitosis, coinciding with an increase in PTEN phosphorylation in the C-terminal
tail. Biochemical and molecular analyses revealed that Plk1 was responsible for PTEN phosphorylation on
S380, a residue not targeted by any other known kinases. We and others have shown that PTEN specifically
interacts with Cdh1 (APC/CCdh1) and WWP2, two ubiquitin E3 ligases. Chromatin PTEN removal during mitotic
exit and the physical interaction between PTEN and Cdh1 was a proteasome-dependnent process.
Furthermore, we observed that a cleaved form of WWP2 specifically is enriched during G2 and mitotic stages,
correlating with chromatin PTEN accumulation. WWP2 silencing accelerates mitotic progression. We
hypothesize that chromatin PTEN plays a crucial role in mitotic progression, whose subcellular
localization and function are controlled by Plk1, Cdh1 and WWP2, and that its molecular deregulation
leads to chromosomal instability and tumor development. To test the validity of our hypothesis, we will
determine whether and how phosphorylation facilitates chromatin translocation of PTEN, dissect the role of
PTEN ubiquitin E3 ligases in regulating its stability, and study the phosphatase-independent function of PTEN
in supressing chromosomal instability and tumor development using both in vivo and in vitro models. Our
proposed studies will not only elucidate the molecular mechanism by which chromatin PTEN is regulated
during the cell cycle, but will also reveal how PTEN functions in maintaining chromosomal stability and
suppressing malignant transformation. This line of research can lead to the identification of new molecular
targets in the PTEN regulatory network that can be explored for cancer drug designs and development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chromatin PTEN: Its Regulation And Functions
-
批准号:10411363
-
项目类别:
-
资助金额:$8.7万
-
财政年份:2017
-
负责人:WEI DAI
-
依托单位:
Chromatin PTEN: Its Regulation And Functions
-
批准号:10689348
-
项目类别:
-
资助金额:$8.76万
-
财政年份:2017
-
负责人:WEI DAI
-
依托单位:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
-
批准号:8250149
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2012
-
负责人:WEI DAI
-
依托单位:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
-
批准号:8958809
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2012
-
负责人:WEI DAI
-
依托单位:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
-
批准号:8572129
-
项目类别:
-
资助金额:$39.69万
-
财政年份:2012
-
负责人:WEI DAI
-
依托单位:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
-
批准号:8413001
-
项目类别:
-
资助金额:$39.29万
-
财政年份:2012
-
负责人:WEI DAI
-
依托单位:
Plk3, A New Player In The Hypoxia Regulatory Networ.
-
批准号:8047101
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:WEI DAI
-
依托单位:
Plk3, A New Player In The Hypoxia Regulatory Networ.
-
批准号:8210839
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:WEI DAI
-
依托单位:
Plk3, A New Player In The Hypoxia Regulatory Networ.
-
批准号:8403837
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2011
-
负责人:WEI DAI
-
依托单位:
Plk3, A New Player In The Hypoxia Regulatory Networ.
-
批准号:8794432
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:WEI DAI
-
依托单位:
Plk3, A New Player In The Hypoxia Regulatory Networ.
-
批准号:8601871
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2011
-
负责人:WEI DAI
-
依托单位:
Growth Control
-
批准号:8038233
-
项目类别:
-
资助金额:$2.46万
-
财政年份:2010
-
负责人:WEI DAI
-
依托单位:
Novel mouse colon cancer models and chemoprevention
-
批准号:7473125
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2006
-
负责人:WEI DAI
-
依托单位:
Novel mouse colon cancer models and chemoprevention
-
批准号:7682059
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2006
-
负责人:WEI DAI
-
依托单位:
A novel mouse colon cancer model and chemoprevention
-
批准号:7903082
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2006
-
负责人:WEI DAI
-
依托单位:
A novel mouse colon cancer model and chemoprevention
-
批准号:7150173
-
项目类别:
-
资助金额:$28.53万
-
财政年份:2006
-
负责人:WEI DAI
-
依托单位:
A novel mouse colon cancer model and chemoprevention
-
批准号:7459171
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2006
-
负责人:WEI DAI
-
依托单位:
Novel mouse colon cancer models and chemoprevention
-
批准号:7279151
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2006
-
负责人:WEI DAI
-
依托单位:
Mammal Cecropins as Antibiotics for Corneal Infections
-
批准号:6739407
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2004
-
负责人:WEI DAI
-
依托单位:
BUBR1 in the Spindle Checkpoint and Tumor Suppression
-
批准号:6732609
-
项目类别:
-
资助金额:$27.9万
-
财政年份:2001
-
负责人:WEI DAI
-
依托单位:
海外基金